CD44: structure, function, and association with the malignant process.

No abstract is available for this paper.

• Publication year

  1997

• Venue

  Advances in Cancer Research

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/S0065-230X(08)60101-3PMID 9111868
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Measurement of an adhesion molecule as an indicator of inflammatory disease activity. Up-regulation of the receptor for hyaluronate (CD44) in rheumatoid arthritis.

  2010cited by this paper
• Human mammary carcinomas express homologues of rat metastasis-associated variants of CD44

  2004cited by this paper
• Somatic cell mutants distinguish CD44 expression and hyaluronic acid binding

  2004cited by this paper
• Molecular maturation of cell adhesion systems during mouse early development

  2004cited by this paper
• Oncogene-dependent expression of CD44 in Balb/c 3T3 derivatives: correlation with metastatic competence

  2004cited by this paper
• Identification and characterization of the human Pgp-1 glycoprotein

  2004cited by this paper
• a 4 Integrins Mediate Lymphocyte Attachment and Rolling under Physiologic Flow

  2004cited by this paper
• Identification of mRNA that encodes an alternative form of H-CAM(CD44) in lymphoid and nonlymphoid tissues

  2004cited by this paper
• Clinical relevance of CD44 cell-surface expression and N-myc gene amplification in a multicentric analysis of 121 pediatric neuroblastomas.

  1996cited by this paper
• Signaling through CD44 Is Mediated by Tyrosine Kinases

  1996cited by this paper
• CD44 and its ligand hyaluronate mediate rolling under physiologic flow: a novel lymphocyte-endothelial cell primary adhesion pathway

  1996cited by this paper
• Expression of a CD44 variant containing exons 8 to 10 is a useful independent factor for the prediction of prognosis in colorectal cancer patients.

  1996cited by this paper
• The CD44 proteins in embryonic development and in cancer.

  1996cited by this paper
• Receptor-Ligand Interaction Between CD44 and Osteopontin (Eta-1)

  1996cited by this paper
• Increasing incidence of CD44v7/8 epitope expression during uterine cervical carcinogenesis

  1996cited by this paper
• In vitro culture of human peripheral blood monocytes induces hyaluronan binding and up-regulates monocyte variant CD44 isoform expression.

  1996cited by this paper
• Expression of variant CD44-messenger RNA in colorectal adenocarcinomas and adenomatous polyps in humans.

  1996cited by this paper
• A cysteine residue located in the transmembrane domain of CD44 is important in binding of CD44 to hyaluronic acid

  1996cited by this paper
• A Splice Variant of CD44 Expressed in the Rat Apical Ectodermal Ridge Contributes to Limb Outgrowth

  1996cited by this paper
• Expression of CD44 isoforms in renal cell tumors. Positive correlation to tumor differentiation.

  1996cited by this paper
• Hyaluronate-independent metastatic behavior of CD44 variant-expressing pancreatic carcinoma cells.

  1996cited by this paper
• Accelerated immune response in transgenic mice expressing rat CD44v4-v7 on T cells.

  1996cited by this paper
• CD44 variant exon epitopes in primary breast cancer and length of survival.

  1995cited by this paper
• The expression of variant CD44 in nasopharyngeal carcinoma is unrelated to expression of LMP-1.

  1995cited by this paper
• COLORECTAL CANCER PROGNOSIS AND EXPRESSION OF EXON-V6-CONTAINING CD44 PROTEINS

  1995cited by this paper
• The MAPK signaling cascade

  1995cited by this paper
• Unusual retention of introns in CD44 gene transcripts in bladder cancer provides new diagnostic and clinical oncological opportunities

  1995cited by this paper
• Regulation of integrin function and cellular adhesion

  1995cited by this paper
• Administration of Antibodies to Hyaluronanreceptor (CD44) Delays the Start and Ameliorates the Severity of Collagen II Arthritis

  1995cited by this paper
• CD44 isoforms in prognosis of breast cancer.

  1995cited by this paper
• Alternative RNA splicing of the hyaluronic acid receptor CD44 in the normal human brain and in brain tumors.

  1995cited by this paper
• Expression of proteoglycans and hyaluronan during wound healing.

  1995cited by this paper
• Effect of CD44v6 on survival in colorectal carcinoma.

  1995cited by this paper
• Prognostic value of CD44 splice variants in human stage III cervical cancer.

  1995cited by this paper
• Expression of cd44 splice variants in human cutaneous melanoma and melanoma cell lines is related to tumor progression and metastatic potential

  1995cited by this paper
• Differentiation and prognosis of neuroblastoma in correlation to the expression of CD44s.

  1995cited by this paper
• Expression of CD44 on rheumatoid synovial fluid lymphocytes.

  1995cited by this paper
• CD-44: a marker of metastases of head and neck melanomas.

  1995cited by this paper
• Anti-CD44 treatment abrogates tissue aedema and leukocyte infiltration in murine arthrtis

  1995cited by this paper
• Importance of different CD44v6 expression in human gastric intestinal and diffuse type cancers for metastatic lymphogenic spreading

  1995cited by this paper
• Schwann cell tumors express characteristic patterns of CD44 splice variants

  1995cited by this paper
• Deregulated alternative splicing of CD44 messenger RNA transcripts in neoplastic and nonneoplastic lesions of the human thyroid.

  1995cited by this paper
• Rolling of lymphocytes and neutrophils on peripheral node addressin and subsequent arrest on ICAM‐1 in shear flow

  1995cited by this paper
• CD44 variant isoforms in non-Hodgkin's lymphoma: a new independent prognostic factor.

  1995cited by this paper
• Effect of transforming growth factor-beta 1 and basic fibroblast growth factor on the expression of cell surface proteoglycans in human lung fibroblasts. Enhanced glycanation and fibronectin-binding of CD44 proteoglycan, and down-regulation of glypican.

  1995cited by this paper
• Involvement of CD44 variant isoforms in hyaluronate adhesion by human activated T cells

  1995cited by this paper
• Cell adhesion molecules on the oocyte and preimplantation human embryo.

  1995cited by this paper
• Hyaluronic acid enhances cell proliferation during eosinopoiesis through the CD44 surface antigen.

  1995cited by this paper
• Variant cell lines selected for alterations in the function of the hyaluronan receptor CD44 show differences in glycosylation

  1995cited by this paper
• CD44 (Pgp-1) inhibits CD3 and dexamethasone-induced apoptosis.

  1995cited by this paper
• Difference in expression of CD44 splice variants between proximal and distal adenocarcinoma of the large bowel

  1995cited by this paper
• CD44 isoforms containing exon V3 are responsible for the presentation of heparin-binding growth factor

  1995cited by this paper
• CD44 isoform expression in primary and metastatic pancreatic adenocarcinoma.

  1995cited by this paper
• Changes in CD44 expression during B cell differentiation in the human tonsil.

  1995cited by this paper
• Glycosylation of CD44 negatively regulates its recognition of hyaluronan

  1995cited by this paper
• HIV Acquires Functional Adhesion Receptors from Host Cells

  1995cited by this paper
• Comparison of immunohistochemistry and RT‐PCR for detection of CD44v‐expression, a new prognostic factor in human breast cancer

  1995cited by this paper
• New CD44 splice variants associated with human breast cancers

  1995cited by this paper
• P-selectin and vascular cell adhesion molecule 1 mediate rolling and arrest, respectively, of CD4+ T lymphocytes on tumor necrosis factor alpha-activated vascular endothelium under flow

  1995cited by this paper
• Non-invasive detection of bladder cancer by identification of abnormal CD44 proteins in exfoliated cancer cells in urine

  1995cited by this paper
• Splice variants of CD44 in human cervical cancer stage IB to IIB.

  1995cited by this paper
• Targeted disruption of CD44 in MDAY-D2 lymphosarcoma cells has no effect on subcutaneous growth or metastatic capacity

  1995cited by this paper
• Transmembrane domain of CD44 is required for its detergent insolubility in fibroblasts.

  1995cited by this paper
• Differential expression and localization of integrins and CD44 in the membrane domains of human uterine epithelial cells during the menstrual cycle.

  1995cited by this paper
• Relation between stage, grade, proliferation, and expression of p53 and CD44 in adenomas and carcinomas of the colorectum.

  1995cited by this paper
• Inhibition of HIV Type 1 Infection of Mononuclear Phagocytes by Anti-CD44 Antibodies

  1995cited by this paper
• Abnormal retention of intron 9 in CD44 gene transcripts in human gastrointestinal tumors.

  1995cited by this paper
• Expression of CD44 in prostate cancer cells: association with cell proliferation and invasive potential.

  1995cited by this paper
• Adhesion molecules on intermediate TCR cells. I. Unique expression of adhesion molecules, CD44+ L-selectin-, on intermediate TCR cells in the liver and the modulation of their adhesion by hyaluronic acid.

  1995cited by this paper
• CD44 isoforms correlate with cellular differentiation but not with prognosis in human breast cancer.

  1995cited by this paper
• Expression of CD44 molecules and CD44 ligands during human thymic fetal development: expression of CD44 isoforms is developmentally regulated.

  1995cited by this paper
• Differential CD44 expression patterns in primary brain tumours and brain metastases.

  1995cited by this paper
• CD44v6 expression in non‐Hodgkin's lymphoma: An association with low histological grade and poor prognosis

  1995cited by this paper
• CD44 isoforms containing exons V6 and V7 are differentially expressed on mitogenically stimulated normal and Epstein-Barr virus-transformed human B cells.

  1995cited by this paper
• Functional hyaluronan receptors are expressed on a squamous cell lung carcinoma cell line but not on other lung carcinoma cell lines.

  1995cited by this paper
• Defective phosphorylation and hyaluronate binding of CD44 with point mutations in the cytoplasmic domain

  1995cited by this paper
• Regulation of CD44 binding to hyaluronan by glycosylation of variably spliced exons

  1995cited by this paper
• Expressions of E-cadherin and exon v6-containing isoforms of CD44 and their prognostic values in human transitional cell carcinoma.

  1995cited by this paper
• Expression of CD44 in human hepatocellular carcinoma cell lines

  1995cited by this paper
• Monoclonal antibodies to CD44 and their influence on hyaluronan recognition

  1995cited by this paper
• Differentiation-associated changes in CD44 isoform expression during normal hematopoiesis and their alteration in chronic myeloid leukemia.

  1995cited by this paper
• Identification of CD44 splice variant in Korean colorectal cancers and cell lines.

  1995cited by this paper
• A CD44 monoclonal antibody differentially regulates CD11a/CD18 binding to intercellular adhesion molecules CD54, CD102 and CD50

  1995cited by this paper
• The clinical significance of malfunction of the CD44 locus in malignancy

  1995cited by this paper
• Proteoglycan forms of the lymphocyte homing receptor CD44 are alternatively spliced variants containing the v3 exon

  1995cited by this paper
• The development of T and non-T cell lineages from CD34+ human thymic precursors can be traced by the differential expression of CD44

  1995cited by this paper
• Differential expression of CD44 splice variants in human pancreatic adenocarcinoma and in normal pancreas.

  1995cited by this paper
• Increased expression of CD44v6 and CD44v3 in ulcerative colitis but not colonic Crohn's disease.

  1995cited by this paper
• Homotypic cell aggregation via conformational change of CD44 molecule induced by anti-CD44 monoclonal antibodies.

  1995cited by this paper
• Regulation of growth and dissemination of a human lymphoma by CD44 splice variants.

  1995cited by this paper
• Evaluation of CD44 prognostic value in neuroblastoma: comparison with the other prognostic factors.

  1995cited by this paper
• Hyaluronan on the surface of tumor cells is correlated with metastatic behavior.

  1995cited by this paper
• Lutheran antigens, CD44-related antigens, and Lutheran regulatory genes.

  1995cited by this paper
• High‐level Expression of the CD44 Variant Sharing Exon v10 in Renal Cancer

  1995cited by this paper
• Comparison of DNA aneuploidy, chromosome 1 abnormalities, MYCN amplification and CD44 expression as prognostic factors in neuroblastoma.

  1995cited by this paper
• Role of CD44 cytoplasmic domain in hyaluronan binding

  1995cited by this paper
• Immunohistochemical and serological evaluation of CD44 splice variants in human ovarian cancer.

  1995cited by this paper
• Hyaluronan binding by CD44 is regulated by a phosphorylation‐independent mechanism

  1995cited by this paper
• CD44 exhibits a cell type dependent interaction with triton X-100 insoluble, lipid rich, plasma membrane domains.

  1995cited by this paper
• Expression of CD44v6 is associated with cellular dysplasia in colorectal epithelial cells.

  1995cited by this paper

• Kidney-targeted nanoplatforms: Strategies and applications

  2026cites this paper
• Overcoming therapeutic challenges in acute myeloid leukemia: active targeting strategies by nano-drug delivery systems.

  2026cites this paper
• RBM10 loss promotes metastases by aberrant splicing of cytoskeletal and extracellular matrix mRNAs.

  2025cites this paper
• CD44 and phosphorylated ERK1/2 coexpression predicts distant metastasis in colorectal cancer based on a study of 1137 Saudi patients

  2025cites this paper
• Macrocyclic peptides targeting human CD44 inhibit cell adhesion.

  2025cites this paper
• CD44 enhances E-selectin-PSGL-1 interaction by binding to distinct sites on E-selectin.

  2025cites this paper
• Scorpion Venom as a Source of Cancer Drugs: A Comprehensive Proteomic Analysis and Therapeutic Potential

  2025cites this paper
• Impacts of Hyaluronan on Extracellular Vesicle Production and Signaling

  2025cites this paper
• Enhanced tumor self-targeting of lemon-derived extracellular vesicles by embedding homotypic cancer cell membranes for efficient drug delivery

  2025cites this paper
• Effects of bromelain supplementation on disease activity and quality of life in patients with ulcerative colitis: a randomized, triple-blind, placebo-controlled study

  2025cites this paper
• SPP1-CD44 signaling contributes to the mechanisms and therapeutic implications in intervertebral disc degeneration.

  2025cites this paper
• Digging into the Solubility Factor in Cancer Diagnosis: A Case of Soluble CD44 Protein

  2025influential citation
• Different features of acute myeloid leukemia stem cell quantification in intensively treated patients

  2025cites this paper
• The Role of Glycans in Human Immunity—A Sweet Code

  2025cites this paper
• Advancements in Cell Membrane-Derived Biomimetic Nanotherapeutics for Breast Cancer

  2025cites this paper
• Update on the Association of CD44 Expression with Esophageal Squamous Cell Carcinoma Invasion.

  2025cites this paper
• Targeting Ischemic Stroke with Neural Stem Cells: Insights into Endogenous Repair Mechanisms, Biomaterial-Based Delivery, and Exosome Therapies

  2025cites this paper
• Crosstalk of injured podocytes with parietal epithelial cells through Wnt4/β-Catenin signaling

  2025cites this paper
• Hyaluronic acid-modified theranostic niosomes for targeted Fingolimod delivery and inhibition of triple-negative breast cancer metastasis

  2025cites this paper
• Lipid Storage, Lipolysis, and Lipotoxicity in Obesity.

  2024cites this paper
• Revolutionizing Lung Cancer Treatment: Nanotechnology-Driven Advances in Targeted Drug Delivery and Novel Therapeutic Strategies

  2024cites this paper
• Cancer cell membrane-coated siRNA-Decorated Au/MnO2 nanosensitizers for synergistically enhanced radio-immunotherapy of breast cancer

  2024cites this paper
• In situ labeling of pretargeted hyaluronan for PET/MR imaging of CD44+ tumors.

  2024cites this paper
• RBM10 loss induces aberrant splicing of cytoskeletal and extracellular matrix mRNAs and promotes metastatic fitness

  2024cites this paper
• Fructose-bisphosphate Aldolase C Expression is Associated with Poor Prognosis and Stemness in Gastric Cancer

  2024cites this paper
• Strain and hyaluronic acid interact to regulate ovarian cancer cell proliferation, migration, and drug resistance

  2024cites this paper
• CD44 Expression in Clear Cell Renal Cell Carcinoma (ccRCC) Correlates with Tumor Grade and Patient Survival and Is Affected by Gene Methylation

  2024cites this paper
• Crosstalk between T lymphocyte and extracellular matrix in tumor microenvironment.

  2024cites this paper
• Robust Synthesis of Targeting Glyco‐Nanoparticles for Surface Enhanced Resonance Raman Based Image‐Guided Tumor Surgery

  2024cites this paper
• Oral N-acetylcysteine ameliorates liver fibrosis and enhances regenerative responses in Mdr2 knockout mice

  2024cites this paper
• Intrinsic and Microenvironmental Drivers of Glioblastoma Invasion

  2024cites this paper
• Expression of CD44, PCNA and E-cadherin in pterygium tissues

  2024cites this paper
• Hyaluronic Acid Hampers the Inflammatory Response Elicited by Extracellular Vesicles from Activated Monocytes in Human Chondrocytes

  2024cites this paper
• Intratracheal Administration of Itraconazole-Loaded Hyaluronated Glycerosomes as a Promising Nanoplatform for the Treatment of Lung Cancer: Formulation, Physiochemical, and In Vivo Distribution

  2024cites this paper
• Current Evidence and Perspectives of Cluster of Differentiation 44 in the Liver’s Physiology and Pathology

  2024cites this paper
• Get Spliced: Uniting Alternative Splicing and Arthritis

  2024cites this paper
• Hyaluronan Metabolism in Urologic Cancers

  2023cites this paper
• Tumor targeted cancer membrane-camouflaged ultra-small Fe nanoparticles for enhanced collaborative apoptosis and ferroptosis in glioma

  2023cites this paper
• Endothelial ICAM-1 Adhesome Recruits CD44 for Optimal Transcellular Migration of Human CTLs.

  2023cites this paper
• Fibrolamellar Carcinomas-Growth arrested by paracrine signals complexed with synthesized 3-O sulfated heparan sulfate oligosaccharides.

  2023cites this paper
• The Stem Cell Expression Profile of Odontogenic Tumors and Cysts: A Systematic Review and Meta-Analysis

  2023cites this paper
• Nanotechnology-integrated ovarian cancer metastasis therapy: Insights from the metastatic mechanisms into administration routes and therapy strategies.

  2023cites this paper
• Hyaluronan and Reactive Oxygen Species Signaling—Novel Cues from the Matrix?

  2023cites this paper
• Collagens Regulating Adipose Tissue Formation and Functions

  2023cites this paper
• Xiaotan Sanjie decoction normalizes tumor permissive microenvironment in gastric cancer (Review).

  2023cites this paper
• Circulating Tumor Cells Adhesion: Application in Biosensors

  2023cites this paper
• CD44s and CD44v8-10 isoforms confer acquired resistance to osimertinib by activating the ErbB3/STAT3 signaling pathway.

  2023cites this paper
• [Relationship between PD-L1 expression and tumor stem cell marker CD44 as a promising basis for the development of new approaches to cancer targeted therapy].

  2023cites this paper
• RNA-binding proteins regulating the CD44 alternative splicing

  2023cites this paper
• Hyaluronan delays human amniotic epithelial stem cell senescence by regulating CD44 isoform switch to activate AKT/mTOR signals.

  2023cites this paper
• miR-204 suppresses cancer stemness and enhances osimertinib sensitivity in non-small cell lung cancer by targeting CD44

  2023cites this paper
• Interaction of Hyaluronan Acid with Some Proteins in Aqueous Solution as Studied by NMR

  2023cites this paper
• CD44 in Bone Metastasis Development: A Key Player in the Fate Decisions of the Invading Cells?

  2023cites this paper
• The v8-10 variant isoform of CD44 is selectively expressed in the normal human colonic stem cell niche and frequently is overexpressed in colon carcinomas during tumor development

  2023cites this paper
• CD44v6 downregulation as a prognostic factor for distant recurrence in resected stage I lung adenocarcinomas

  2023cites this paper
• Tumorigenic effects of human mesenchymal stromal cells and fibroblasts on bladder cancer cells

  2023cites this paper
• The Glycosaminoglycan Side Chains and Modular Core Proteins of Heparan Sulphate Proteoglycans and the Varied Ways They Provide Tissue Protection by Regulating Physiological Processes and Cellular Behaviour

  2023cites this paper
• The Role of Membrane-Type 1 Matrix Metalloproteinase–Substrate Interactions in Pathogenesis

  2023cites this paper
• ERBB2 and ERBB3 Growth Factor Receptors, Neuregulin-1, CD44 and Ki-67 Proliferation Index in Neurofibromatosis Type 1-associated Peripheral Nerve Sheath Tumors

  2022cites this paper
• Role of Intracellular Iron in Switching Apoptosis to Ferroptosis to Target Therapy-Resistant Cancer Stem Cells

  2022cites this paper
• Hyaluronic Acid: Known for Almost a Century, but Still in Vogue

  2022cites this paper
• Applications of Iron Oxide Nanoparticles against Breast Cancer

  2022cites this paper
• CAR-T Cell Therapy for Breast Cancer: From Basic Research to Clinical Application

  2022cites this paper
• CD44-Targeted Nanocarrier for Cancer Therapy

  2022cites this paper
• Castanospermine suppresses CD44 ectodomain cleavage as revealed by transmembrane bioluminescent sensors.

  2022cites this paper
• Glycoproteogenomics characterizes the CD44 splicing code associated with bladder cancer invasion

  2022cites this paper
• Mechanism of ketotifen fumarate inhibiting renal calcium oxalate stone formation in SD rats.

  2022cites this paper
• Dual targeting nanoparticles based on hyaluronic and folic acids as a promising delivery system of the encapsulated 4-Methylumbelliferone (4-MU) against invasiveness of lung cancer in vivo and in vitro.

  2022cites this paper
• Biomimetic cell-derived nanocarriers in cancer research

  2022cites this paper
• DeepCCI: a deep learning framework for identifying cell–cell interactions from single-cell RNA sequencing data

  2022cites this paper
• Hyaluronidase treatment of synovial fluid is required for accurate detection of inflammatory cells and soluble mediators

  2022cites this paper
• RNAi-based therapeutics and tumor targeted delivery in cancer.

  2022cites this paper
• Characterization of Hyaluronic Acid-Coated PLGA Nanoparticles by Surface-Enhanced Raman Spectroscopy

  2022cites this paper
• The rs13347 Polymorphism of the CD44 Gene Is Associated with the Risk of Kidney Stones Disease in the Chinese Han Population of Northeast Sichuan, China

  2022cites this paper
• Flap-enabled next-generation capture (FENGC): precision targeted single-molecule profiling of epigenetic heterogeneity, chromatin dynamics, and genetic variation

  2022cites this paper
• Cancer and Apoptosis.

  2022cites this paper
• CD44a functions as a regulator of p53 signaling, apoptosis and autophagy in the antibacterial immune response

  2022cites this paper
• Proteolytic modulation of tumor microenvironment signals during cancer progression

  2022cites this paper
• Over Expression of Cancer Stem Cell Marker CD44 and Its Clinical Significance in Patients with Oral Squamous Cell Carcinoma

  2022cites this paper
• CD24: A Novel Target for Cancer Immunotherapy

  2022cites this paper
• CD44 receptor targeted nanoparticles augment immunity against tuberculosis in mice.

  2022cites this paper
• A Novel Detection Method of Breast Cancer through a Simple Panel of Biomarkers

  2022cites this paper
• Functionalized nanoparticles targeting biomarkers for prostate cancer imaging and therapy.

  2022cites this paper
• Molecular Alterations in Malignant Pleural Mesothelioma: A Hope for Effective Treatment by Targeting YAP

  2022cites this paper
• The lipid rafts in cancer stem cell: a target to eradicate cancer

  2022cites this paper
• Phase I trial of daily subcutaneous SPL-108 injections in combination with paclitaxel in patients with platinum resistant CD44+ advanced ovarian epithelial cancer

  2022cites this paper
• Multiscale Modeling of MT1-MMP-Mediated Cell Migration: Destabilization of Cell-Matrix Adhesion

  2022cites this paper
• Mass Cytometry Study on Hepatic Fibrosis and Its Drug-Induced Recovery Using Mouse Peripheral Blood Mononuclear Cells

  2022cites this paper
• The uptake of metal–organic frameworks: a journey into the cell

  2022cites this paper
• Extracellular matrix dynamics: tracking in biological systems and their implications

  2022cites this paper
• Recent advances in the design of inorganic and nano-clay particles for the treatment of brain disorders.

  2021cites this paper
• Cancer Cell Membrane Camouflaged Mesoporous Silica Nanoparticles Combined with Immune Checkpoint Blockade for Regulating Tumor Microenvironment and Enhancing Antitumor Therapy

  2021cites this paper
• Bacterial Genotoxin-Coated Nanoparticles for Radiotherapy Sensitization in Prostate Cancer

  2021cites this paper
• In Silico Design and Selection of New Tetrahydroisoquinoline-Based CD44 Antagonist Candidates

  2021cites this paper
• Proteolytic Processing of CD44 and Its Implications in Cancer

  2021cites this paper
• The Breast Cancer Stem Cells Traits and Drug Resistance

  2021cites this paper
• Blood-Derived Biomarkers of Diagnosis, Prognosis and Therapy Response in Prostate Cancer Patients

  2021cites this paper
• CD44 and Tumor-Derived Extracellular Vesicles (TEVs). Possible Gateway to Cancer Metastasis

  2021cites this paper
• Evaluation of CD44 and TGF-B Expression in Oral Carcinogenesis

  2021influential citation
• Engineering polymer nanoparticles using cell membrane coating technology and their application in cancer treatments: Opportunities and challenges

  2021cites this paper